SCHEMBL22547832

SCHEMBL22547832

CCc1cc(-c2nnc(O)n2-c2ccc(CN3CCC(C(=O)N4CCC(CNC(C)=O)C4)CC3)cc2)c(O)cc1O

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CCR3 P51677 1/20 0.39
▸ BRD4 O60885 3/20 0.39
▸ KCNH2 Q12809 2/20 0.38
▸ CACNA1I Q9P0X4 2/20 0.38
▸ TP53 P04637 2/20 0.37
▸ HSP90AA1 P07900 1/20 0.36
▸ HSP90AB1 P08238 1/20 0.36
▸ ACKR3 P25106 2/20 0.36
▸ ERCC1 P07992 1/20 0.36
▸ ERCC4 Q92889 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ LTA4H P09960 1/20 0.35
▸ PARP1 P09874 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22541290 0.88 BRD4 (0.41) BRD4HSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL24334860 0.86 BRD4 (0.40) BRD4HSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL22541280 0.85 HSP90AA1 (0.38) CCR3BRD4HSP90AA1HSP90AB1
SCHEMBL22548269 0.85 CCR3 (0.39) CCR3HSP90AA1HSP90AB1
SCHEMBL22541229 0.81 BRD4 (0.47) BRD4KCNH2HSP90AA1HSP90AB1
SCHEMBL22548219 0.81 CCR2 (0.40) BRD4HSP90AA1HSP90AB1
SCHEMBL22548154 0.81 HSP90AA1 (0.39) CCR3HSP90AA1HSP90AB1
SCHEMBL22541300 0.78 HSP90AA1 (0.40) BRD4HSP90AA1HSP90AB1KDM4EALDH1A1
SCHEMBL24477130 0.77 BRD4 (0.44) CCR3BRD4KCNH2HSP90AA1HSP90AB1
SCHEMBL22541216 0.77 BRD4 (0.41) CCR3BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020207396-A1 METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION RANOK THERAPEUTICS (HANGZHOU) CO. LTD. (CN) 2020-10-15 — — WO disclosed
Send feedback